Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Intellicheck, Inc.IDN · Entity 7153 | Chief Technology Officer | June 15, 2026 | June 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Intellicheck, Inc.
Report date June 15, 2026 · Filed June 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.001 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-06-15 transaction · row 1
1 source rowRow 1 · 2026-06-15 · Sale · Disposed 5,550 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2026 Filed Jun 16, 2026 21:00 UTC | Intellicheck, Inc. IDN · Entity 7153 | SaleCommon Stock, $.001 par value | 5,550 | $4.22 | $23,421.00 |
DisclosureSEC source: 0001996464-26-000004 · wk-form4_1781643635.xml · nonDerivative · entry 1 Robins Jonathan · CIK 0001996464 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 24, 2026 Filed Mar 26, 2026 20:49 UTC | Intellicheck, Inc. IDN · Entity 7153 | GrantStock Option (Right to Buy) · Derivative | 77,000 | $0.00 Strike: $5.60 | $0.00 |
DisclosureSEC source: 0001996464-26-000002 · wk-form4_1774558179.xml · derivative · entry 1 Robins Jonathan · CIK 0001996464 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,000 Underlying: Common Stock, $.001 par value · 77,000 shares Expires 2033-03-24 F1 · derivative.exercise_date: One-third of this Option shall vest upon the first anniversary of the date of grant and the remaining two-thirds of this Option shall vest quarterly over the following two years Read SEC document |
| April 25, 2025 Filed Apr 29, 2025 20:44 UTC | Intellicheck, Inc. IDN · Entity 7153 | GrantStock Option (Right to Buy) · Derivative | 77,000 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001628280-25-020740 · wk-form4_1745959454.xml · derivative · entry 1 Robins Jonathan · CIK 0001996464 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,000 Underlying: Common Stock, $.001 par value · 77,000 shares Expires 2030-04-25 F1 · derivative.exercise_date: One-third of this Option shall vest upon the first anniversary of the date of grant and the remaining two-thirds of this Option shall vest quarterly over the following two years Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:00 UTC | Intellicheck, Inc. IDN · Entity 7153 | GrantStock Option (Right to Buy) · Derivative | 17,500 | $2.17 Strike: $2.17 | $37,975.00 |
DisclosureSEC source: 0001628280-24-011904 · wk-form4_1710878419.xml · derivative · entry 3 Robins Jonathan · CIK 0001996464 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock, $.001 par value · 17,500 shares Expires 2031-03-15 F1 · derivative.exercise_price: Of these options, 50% (35,000) have no premium (i.e. exercise price equals stock price at grant); 25% (17,500) of the options have a 10% premium (i.e. exercise price equals stock price at grant plus 10%); and 25% (17,500) of the options have a 20% premium (i.e. exercise price equals stock price at grant plus 20%). F2 · derivative.exercise_date: One-third of this Option shall vest upon the first anniversary of the date of grant and the remaining two-thirds of this Option shall vest quarterly over the following two years Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:00 UTC | Intellicheck, Inc. IDN · Entity 7153 | GrantStock Option (Right to Buy) · Derivative | 17,500 | $1.99 Strike: $1.99 | $34,825.00 |
DisclosureSEC source: 0001628280-24-011904 · wk-form4_1710878419.xml · derivative · entry 2 Robins Jonathan · CIK 0001996464 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock, $.001 par value · 17,500 shares Expires 2031-03-15 F1 · derivative.exercise_price: Of these options, 50% (35,000) have no premium (i.e. exercise price equals stock price at grant); 25% (17,500) of the options have a 10% premium (i.e. exercise price equals stock price at grant plus 10%); and 25% (17,500) of the options have a 20% premium (i.e. exercise price equals stock price at grant plus 20%). F2 · derivative.exercise_date: One-third of this Option shall vest upon the first anniversary of the date of grant and the remaining two-thirds of this Option shall vest quarterly over the following two years Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:00 UTC | Intellicheck, Inc. IDN · Entity 7153 | GrantStock Option (Right to Buy) · Derivative | 35,000 | $1.81 Strike: $1.81 | $63,350.00 |
DisclosureSEC source: 0001628280-24-011904 · wk-form4_1710878419.xml · derivative · entry 1 Robins Jonathan · CIK 0001996464 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock, $.001 par value · 35,000 shares Expires 2031-03-15 F1 · derivative.exercise_price: Of these options, 50% (35,000) have no premium (i.e. exercise price equals stock price at grant); 25% (17,500) of the options have a 10% premium (i.e. exercise price equals stock price at grant plus 10%); and 25% (17,500) of the options have a 20% premium (i.e. exercise price equals stock price at grant plus 20%). F2 · derivative.exercise_date: One-third of this Option shall vest upon the first anniversary of the date of grant and the remaining two-thirds of this Option shall vest quarterly over the following two years Read SEC document |
| December 14, 2023 Filed Dec 14, 2023 21:23 UTC | Intellicheck, Inc. IDN · Entity 7153 | PurchaseCommon Stock, $.001 par value | 5,000 | $1.80 | $9,000.00 |
DisclosureSEC source: 0001628280-23-041589 · wk-form4_1702589020.xml · nonDerivative · entry 1 Robins Jonathan · CIK 0001996464 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,200 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.